Tareq Abadl: The Hidden Danger in a Blood Bag – When a Unit Looks ‘Wrong’
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“The Hidden Danger in a Blood Bag: When a Unit Looks ‘Wrong’
Did you know that if a blood bag contains visible clots or fibrin strands, it should not be transfused?
Many people think transfusion safety is only about ABO, Rh, and antibody testing — but sometimes the warning sign is something you can actually see with the naked eye.
Blood components are collected into bags containing anticoagulants to prevent clotting. However, clotting activation can still occasionally occur, leading to the formation of:
- Clots
- Fibrin strands
- Clumps or aggregates
- Abnormal discoloration or appearance
Why is this important?
Because visible clots or fibrin strands may indicate:
- Activation of the coagulation process
- Product quality deterioration
- Improper storage or handling
- Potential risk to the patient if transfused
That is why blood-bank personnel and transfusion services perform careful visual inspection before releasing blood products.
A unit may be rejected even if:
- The blood type is correct
- Compatibility testing is acceptable
- The label appears normal
If unusual findings are seen, the component should be:
- Returned to the transfusion service
- Investigated further
- Withheld from transfusion until deemed safe
Another important laboratory point:
Different blood components can show different abnormal appearances.
For example:
- RBC units can show clots, hemolysis, dark discoloration
- Plasma can show unusual turbidity or color change
- Platelets can show clumping or loss of the normal swirling appearance
This is one of the most fascinating parts of medical laboratory science in transfusion medicine:
Blood-bank safety is not only about compatibility testing — it also includes visual inspection, storage monitoring, quality control, and product release safety.”
Other posts featuring Tareq Abadl on Hemostasis Today.
-
Sep 19, 2026, 03:15Paulus Kirchhof: Europe’s Safe Hearts Plan to Reduce Cardiovascular Mortality
-
Sep 19, 2026, 03:10James Smith: Brain Training and Exercise for Cognitive Recovery After Stroke
-
Sep 19, 2026, 03:03Lesley Van Wyk: ASH Releases New Iron Deficiency Diagnosis Guidelines
-
Sep 19, 2026, 02:53Francisco Chacón-Lozsán: Acute Ischemic Stroke in 2026 – Expanding the Treatment Window
-
Sep 19, 2026, 01:53Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology
-
Sep 19, 2026, 01:47Abdurrahman Tufan: Combination Targeted Therapy in Refractory Systemic Autoinflammatory Diseases
-
Sep 19, 2026, 01:44Patrick James Lynch: Mother of a Thousand Sons Premieres at BDC 2026
-
Sep 19, 2026, 01:41Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
-
Sep 19, 2026, 01:39Mostafa Hammam: Three Different Platelet Defects – One Common Symptom